Tyler M. Thompson

Senior Advisor

Washington, D.C.
T +1.202.861.1571
F +1.202.861.1783

Overview

Tyler Thompson has nearly 20 years of experience in regulatory, legislative and policy matters related to healthcare, access to affordable pharmaceuticals and medical devices, and occupational and workplace safety, both in and outside of government. Through this work, Tyler forged strong relationships with key members and staff in House and Senate leadership, as well as relevant committees of jurisdiction in both chambers, on both sides of the aisle and in the Administration.

Tyler was a top advisor to Senator Johnny Isakson and served in a number of positions in the United States Senate for over 10 years, focusing primarily on healthcare and OSHA policy, as well as appropriations. Since leaving Capitol Hill in 2012, Tyler has served as a lead consultant to a diverse group of clients across numerous industries, including technology innovators, industrial manufacturers, pharmaceutical and medical device companies, nonprofit children’s hospitals and major trade associations.

Tyler works in a thoughtful, bipartisan manner to bridge gaps between opposing viewpoints and employs a keen understanding of administrative and legislative procedures to provide informed strategic advice and effective execution on behalf of clients.

*Not an Attorney

Select Experience

  • Worked to reform Medicaid policy related to children’s healthcare needs through involvement in the Children’s Hospital Graduate Medical Education Reauthorization policy.
  • Represented clients in meetings and substantive work with OSHA and relevant committees on Capitol Hill to further their interests though regulatory and legislative processes.
  • Navigated policies and procedures while providing substantive work and strategic analysis of the Affordable Care Act for a key US Senator.
More »

Experience

  • Worked to reform Medicaid policy related to children’s healthcare needs through involvement in the Children’s Hospital Graduate Medical Education Reauthorization policy.
  • Represented clients in meetings and substantive work with OSHA and relevant committees on Capitol Hill to further their interests though regulatory and legislative processes.
  • Navigated policies and procedures while providing substantive work and strategic analysis of the Affordable Care Act for a key US Senator.
  • Collaborated with opposing viewpoints during discussions on the Hope Offered Through Principled and Ethical Stem Cell Research (HOPE) Act. Used strong communication to assist in development of policies that addressed interests of all parties on controversial topic.
  • Negotiated and compromised with opposing parties throughout development of the Drug Quality of Security Act.
  • Involved in development of legislative policies related to pharmaceutical and medical device industry, including the Prescription Drug User Fee Act, Medical Device User Fee Act, Animal Drug User Fee Act, Biologics Price and Competition Act, Pandemic and All-Hazards Preparedness Act, and Medicare Modernization Act. Used combined knowledge of policies and politics at play to advance specific interests while remaining sensitive to stances of opposing parties.
  • Advised Senators and healthcare industry clients on healthcare regulations and policies within the Department of Health and Human Services. Provided additional advice on healthcare issues concerning, among other things, CDC and NIH budget formulation and appropriations and OMB policy.

Recognitions and Memberships

Industries

Prior Positions

  • The Bockorny Group: Principal and Healthcare Practice Lead (2012 to 2013)
  • Legislative Assistant for United States Senator Johnny Isakson (2005 to 2012)
  • Legislative Correspondent for United States Senator Saxby Chambliss (2005)
  • Legislative Correspondent for United States Senator Zell Miller (2002 to 2005)

Admissions

  • [Not an Attorney]

Education

  • B.A., History, Sewanee: The University of the South, 2002

Blog

In The Blogs

Previous Next
Ohio Clock
The Weekly Hill Update, May 30, 2023
By Adam J. Higgins
May 30, 2023
Below is this week’s congressional update by BakerHostetler’s Federal Policy team. We’ll continue to post in weeks when both chambers of Congress are in session. HEADLINES HOUSE SENATE WHITE HOUSE Friday, Biden will attend the Friday...
Read More ->
Ohio Clock
The Weekly Hill Update, May 15, 2023
By Adam J. Higgins
May 15, 2023
Below is this week’s congressional update by BakerHostetler’s Federal Policy team. We’ll continue to post in weeks when both chambers of Congress are in session. HEADLINES HOUSE SENATE WHITE HOUSE… Continue Reading
Read More ->
Ohio Clock
The Weekly Hill Update May 8, 2023
By Adam J. Higgins
May 8, 2023
Below is this week’s congressional update by BakerHostetler’s Federal Policy team. We’ll continue to post in weeks when both chambers of Congress are in session. HEADLINES HOUSE SENATE WHITE HOUSE… Continue Reading
Read More ->
Ohio Clock
U.S. Treasury Dept. Publishes Risk Assessment Addressing Illicit Finance Risks of DeFi - Ohio Clock
By Kevin R. Edgar
April 24, 2023
The Federal Policy team’s Kevin Edgar co-authored an analysis of the U.S. Treasury’s recent report on how bad actors are increasingly exploiting decentralized finance services for criminal activities. Kevin and members of BakerHostetler’s...
Read More ->
Ohio Clock
The Weekly Hill Update - April 24, 2023
By Adam J. Higgins
April 24, 2023
Below is this week’s congressional update by BakerHostetler’s Federal Policy team. We’ll continue to post in weeks when both chambers of Congress are in session. HEADLINES HOUSE SENATE WHITE HOUSE Friday, the president will present the...
Read More ->